| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2230-0054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2220-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2220-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-9583
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-91575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-9155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0029
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-91558 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-915
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-966
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-844
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-07 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-958 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-966
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-915
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-07 |
| filingDate |
2011-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2018-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101869998-B1 |
| titleOfInvention |
Stent |
| abstract |
The present invention relates to a medical device and a method of using the medical device. A device is a stent that can be delivered through the skin using an intravascular catheter (or on a catheter) or by other surgery or other techniques, and then expanded. The stent is configured to have a central portion defined by an "open" cell and at least two ends formed and spaced apart by a "closed" cell and directly connected to the distal and proximal ends of the central portion of the stent. The stent may also optionally have a lattice with a covering or opening. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102270438-B1 |
| priorityDate |
2011-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |